Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Invitrogen™ MXD1 Polyclonal Antibody
GREENER_CHOICE

Rabbit Polyclonal Antibody

Supplier:  Invitrogen™ PA517613

Catalog No. PIPA517613


Only null left
Add to Cart

Description

Description

It is not recommended to aliquot this antibody. This antibody is not cross-reactive with other Mad family members at physiological levels.

MAX dimerization protein belongs to a subfamily of MAX-interacting proteins. This protein competes with MYC for binding to MAX to form a sequence-specific DNA-binding complex, acts as a transcriptional repressor (while MYC appears to function as an activator) and is a candidate tumor suppressor.
TRUSTED_SUSTAINABILITY
Specifications

Specifications

MXD1
Polyclonal
Unconjugated
MXD1
antagonizer of myc transcriptional activity; AW122478; BHLHC58; Mad; Mad1; Mad-1; max dimerization protein 1; Max dimerizer 1; MAX-binding protein; MGC104659; mxd1; OTTHUMP00000202211; Protein MAD; si:dkey-202n14.4
Rabbit
Antigen affinity chromatography
RUO
17119, 362391, 4084
-20°C
Liquid
Western Blot
29 μg/mL
0.01M HEPES with 100μg/mL BSA, 50% glycerol, 0.15M NaCl and no preservative; pH 7.5
P50538, Q05195
MXD1
Synthetic peptide corresponding to the carboxy terminus region of Mad-1.
100 μL
Primary
Human, Mouse, Rat
Antibody
IgG
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.